APO-Fluoxetine (2015-04-17) Apr 17, 2015 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength Bottle of 100 Capsules: Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA A. APO-Fluoxetine Capsule DIN 02216361 Fluoxetine (Fluoxetine hydrochloride) 20 mg
Recalled products
APO-Fluoxetine
The active pharmaceutical ingredient (API) used in the manufacturing of these lots may not meet the specification for impurity - isobutyl vinyl ketone (IBVK)